CFB
ENZ

Cullen/Frost Bankers’s Enzo Biochem, Inc. ENZ Stock Holding History

Cullen/Frost Bankers’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-102,772
Closed -$428K – 389
2014
Q1 		$428K Hold
102,772
– – 0.02% 298
2013
Q4 		$300K Hold
102,772
– – 0.01% 319
2013
Q3 		$259K Hold
102,772
– – 0.01% 335
2013
Q2 		$214K Buy
+102,772
New +$227K 0.01% 350

Other funds holding ENZ

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

Cullen/Frost Bankers's ENZ Position: Q2 2014 in Review

Cullen/Frost Bankers sold out of Enzo Biochem, Inc. (ENZ) in Q2 2014, closing a stake of 102,772 shares — an estimated $428K sold.

Cullen/Frost Bankers first reported a position in ENZ in Q2 2013 and held it in 4 quarters. The position peaked at $428K in Q1 2014. 86 funds tracked by Wall St. Rank hold ENZ as of Q2 2014.

  • Cullen/Frost Bankers reported no remaining Enzo Biochem, Inc. position as of Q2 2014 after selling out during the quarter.
  • Cullen/Frost Bankers sold 102,772 Enzo Biochem, Inc. shares in Q2 2014, an estimated $428K.
  • Cullen/Frost Bankers first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 4 quarters.
  • Cullen/Frost Bankers's Enzo Biochem, Inc. position peaked at $428K in Q1 2014.
  • 86 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2014.

Based on Cullen/Frost Bankers's 13F filing for Q2 2014, filed 5 Aug 2014.